The Cape Town-based biotechnology firm, Afrigen Biologics, has officially entered business rescue. This move follows the financial collapse of the Avacare group, which holds a 51% majority stake in the company. The Industrial Development Corporation (IDC) holds the remaining 49% share. Afrigen gained international acclaim in 2022. It successfully developed an mRNA COVID-19 vaccine using publicly available data from Moderna.…